Sangamo BioSciences, Inc.
Total Awards:
2
Award Value:
$7,910,540
Institution type:
For profit
Short Name:
Sangamo
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Bettina Cockroft | A Phase 1/2 Study to Assess the Safety, Tolerability, and Efficacy of ST-400 Autologous HSPC Transplant in Transfusion-dependent β-Thalassemia | $5,150,000 |
| Strategic Partnership II | Dr. Fyodor D Urnov | A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells | $2,760,540 |
| Total: $7,910,540.00 |
